Anzeige
Mehr »
Freitag, 24.10.2025 - Börsentäglich über 12.000 News
Das Comeback des Goldrauschs - diesmal ausgelöst durch eine Währungskrise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DGQ3 | ISIN: SE0009242654 | Ticker-Symbol: 8V6
Frankfurt
23.10.25 | 08:14
0,381 Euro
-2,81 % -0,011
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SCANDINAVIAN CHEMOTECH AB Chart 1 Jahr
5-Tage-Chart
SCANDINAVIAN CHEMOTECH AB 5-Tage-Chart

Aktuelle News zur SCANDINAVIAN CHEMOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.10.Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide91Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed...
► Artikel lesen
01.10.Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown82Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking...
► Artikel lesen
26.09.Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion430Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland....
► Artikel lesen
19.09.Scandinavian ChemoTech Hosts Successful TSE Best Practice Sharing Session with Dr. Brendan Boostrom1
SCANDINAVIAN CHEMOTECH Aktie jetzt für 0€ handeln
10.09.Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology74Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the...
► Artikel lesen
25.08.Scandinavian ChemoTech Expands in Florida with Fourth Veterinary Oncology Clinic Partnership2
20.08.Scandinavian ChemoTech's Animal Care Surpasses 2,500 Treatment-kits sold Worldwide2
12.08.Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025120Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's...
► Artikel lesen
29.07.Scandinavian ChemoTech Welcomes Strategic Investors from the announce Directed Share Issue to Accelerate Global Growth2
27.07.Scandinavian ChemoTech AB (publ) carries out a directed share issue and receives approximately 4.85 MSEK2
25.07.(RETRANS) Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation1
24.07.Scandinavian ChemoTech's TSE Treatment Shows High Response Rate in Veterinary Cancer Study - Validated by Approved PhD Dissertation1
01.07.Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025139Scandinavian ChemoTech AB's Animal Care division proudly announces record-breaking sales in the second quarter of 2025. With continued momentum from a strong start to the quarter, the team achieved...
► Artikel lesen
06.05.Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q1 2025131Scandinavian ChemoTech AB (publ) hereby publishes the Interim Report for Q1 2025. First-quarter sales reached 2 472 KSEK, which is the best quarter so far. All sales originated from Animal Care. First...
► Artikel lesen
04.03.Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-End Report January - December 2024148Scandinavian ChemoTech AB (publ) hereby publishes the Year-End Report for 2024. Fourth-quarter sales reached 2 041 KSEK, which is the best quarter in 2024. Total annual sales amounted to 6 566 KSEK-entirely...
► Artikel lesen
30.01.Scandinavian ChemoTech AB: Scandinavian ChemoTech Restructures Loans and Doubles the Duration to 12 Months204ChemoTech is pleased to announce the signing of new restructured loan agreements to replace its previous short-term bridge financing. The new agreements include a 2.4 MSEK loan from two external investors...
► Artikel lesen
24.01.Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care operations showed positive cashflow for 2024 in separate reporting222Scandinavian ChemoTech is pleased to announce that our Animal Care operations would already be showing a positive cash flow if we reported our business areas separately. This underscores the importance...
► Artikel lesen
09.01.Scandinavian ChemoTech AB: Scandinavian ChemoTech Implements Management Changes to Reduce Costs and Boost Revenues171Scandinavian ChemoTech AB, in line with the structural changes for the group published on December 30, 2024, has decided to implement measures aimed at achieving financial sustainability. As part of...
► Artikel lesen
30.12.24Scandinavian ChemoTech AB: Scandinavian ChemoTech Splits Business Units to Boost Cash Flow and will suggest a new name for the group224Since 2021, Scandinavian ChemoTech has operated two distinct business units - Human Care and Animal Care. While Human Care was the group's initial focus, the Board of Directors has made key decisions...
► Artikel lesen
29.11.24Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care division is heading for a strong fourth quarter 2024 in terms of sales155Animal Care is on track to close 2024 on a high note, with sales in the fourth quarter already reaching approximately 1,500 KSEK and projected to surpass 6,000 KSEK for the full year. This highlights...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1